Search for content, post, videos
Biotech Stocks Getting Lots of Love:  Exelixis, Inc. (EXEL), Celgene Corporation (CELG), Adaptimmune Therapeutics PLC (ADAP)

  Exelixis, Inc. (NASDAQ:EXEL) advanced 10.42% to end last trading session at $5.51. The company on December 23, 2015 announced that it has completed the submission of its rolling New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for cabozantinib as a treatment for patients with advanced…

3 Biotech Stocks Getting Some Love: Cempra Inc (CEMP), Discovery Laboratories, Inc. (DSCO), Synta Pharmaceuticals Corp. (SNTA)

  Cempra Inc (NASDAQ:CEMP) advanced 8.40% to end last trading session at $30.72. The company on Dec. 22, 2015 announced it has successfully completed enrollment of 250 patients in the United States and Australia for its Phase 3 trial in urogenital gonorrhea. Under a CRADA (Cooperative Research and Development Agreement)…